Antiemetic neurokinin-1 antagonist aprepitant and ifosfamide-induced encephalopathy.
Durand
J-P
JP
Gourmel
B
B
Mir
O
O
Goldwasser
F
F
D000932:Antiemetics / Q000009:adverse effects*; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D000077608:Aprepitant; D001927:Brain Diseases / Q000139:chemically induced*; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000502:physiology; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects* / Q000378:metabolism; D008875:Middle Aged; D009025:Morpholines / Q000009:adverse effects*
D000932:Antiemetics; D018906:Antineoplastic Agents, Alkylating; D009025:Morpholines; D000077608:Aprepitant; D003577:Cytochrome P-450 Enzyme System; D051544:Cytochrome P-450 CYP3A; C510163:CYP3A4 protein, human; D007069:Ifosfamide